Advertisement

Regulation of Cardiac Contractility and Glycolysis by Cyclic Nucleotides during Hypoxia

  • T. Metsä-Ketelä
  • K. Laustiola
  • H. Vapaatalo

Abstract

It has been suggested that cyclic nucleotides (cAMP and cGMP) participate in the regulation of cardiac contractility and glycolysis. In the present study, this possible involvement was examined in spontaneously beating rat atria during hypoxia (50% oxygen saturation). Thirty seconds after reduction of high oxygen saturation (HiOxSa) in the incubation medium, the contraction amplitude declined to 50% of the initial level. The decline was partly antagonized by norepinephrine (NE) or hypercalcemia. The cAMP level remained unchanged during hypoxia, but the cGMP content gradually increased. Paradoxically, the production of lactate decreased after 30 sec of hypoxia but had increased by 2 min, when depletion of creatine phosphate and ATP stores was also initiated. Sodium nitroprusside (nitroprusside) and NE elevated the cGMP and cAMP, respectively, in both HiOxSa and hypoxia. Nitroprusside and NE also showed a positive inotropic effect in HiOxSa. Verapamil decreased contractility without changing the levels of cAMP or cGMP. In HiOxSa, both nitroprusside and verapamil decreased lactate production but were not able to resist the increase in atrial lactate level brought about by NE. In hypercalcemia the amplitude increased, but lactate production was slightly reduced in HiOxSa. Between 5 and 10 min of hypoxia, 45Ca uptake was reduced to about one-third of that in the control. It is suggested that lack of oxygen has direct and parallel effects on the sarcolemma and the mitochondria. The former induces deterioration of contractility, the latter termination of aerobic energy production. Cyclic nucleotides are not involved in either of these phenomena. However, at a low rate of anaerobic glycolysis, e.g., in HiOxSa or at the very early stage of hypoxia, cGMP could inhibit and cAMP accelerate lactate production.

Keywords

Sodium Nitroprusside Cyclic Nucleotide Lactate Production Creatine Phosphate Cardiac Contractility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abiko, Y., Ichihara, K., and Izumi, T. 1979. Effects of antianginal drugs on ischemic myocardial metabolism. In: M. M. Winbury and Y. Abiko (eds.), Perspectives in Cardiovascular Research, Vol. 3, pp. 155–169. Raven Press, New York.Google Scholar
  2. 2.
    Beitner, R., Haberman, S., and Cycowitz, T. 1977. The effect of cyclic GMP on phos-phofructokinase from rat tissues. Biochim. Biophys. Acta 482:330–340.PubMedCrossRefGoogle Scholar
  3. 3.
    Beitner, R., Haberman, S., Nordenberg, J., and Cohen, T. 1978. The levels of cyclic GMP and glucose 1,6-diphosphate, and the activity of phosphofructokinase, in muscle from normal and dystrophic mice. Biochim. Biophys. Acta 542:537–541.PubMedCrossRefGoogle Scholar
  4. 4.
    Dinnendahl, V. A. 1974. A rapid and simple procedure for the determination of guanosine 3′,5′-monophosphate by use of the protein-binding method. Naunyn Schmiedebergs Arch. Pharmacol. 284:55–61.PubMedCrossRefGoogle Scholar
  5. 5.
    George, W. J., Poison, J. B., O’Toole, A. G., and Goldberg, N. D. 1970. Elevation of guanosine 3’,5’-cyclic phosphate in rat heart after perfusion with acetylcholine. Proc. Natl. Acad. Sci. U.S.A. 66:398–403.PubMedCrossRefGoogle Scholar
  6. 6.
    Gevers, W. 1977. Generation of protons by metabolic processes in heart cells. J. Mol. Cell. Cardiol. 9:867–874.PubMedCrossRefGoogle Scholar
  7. 7.
    Gilman, A. G. 1970. A protein-binding assay for adenosine 3’,5’-cyclic monophosphate. Proc. Natl. Acad. Sci. U.S.A. 67:305–312.PubMedCrossRefGoogle Scholar
  8. 8.
    Glass, D. B., and Krebs, E. G. 1980. Protein phosphorylation catalyzed by cyclic AMP-dependent and cyclic GMP-dependent protein kinases. Annu. Rev. Pharmacol. Toxicol. 20:363–388.PubMedCrossRefGoogle Scholar
  9. 9.
    Goldberg, N. D., Haddox, M. K., Nicol, S. E., Glass, D. B., Sanford, C. H., Kuehl, F. A., Jr., and Estensen, R. 1975. Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: The yin yang hypothesis. Adv. Cyclic Nucleotide Res. 5:307–330.PubMedGoogle Scholar
  10. 10.
    Gudbjarnason, S., Mathes, P., and Ravens, K. G. 1970. Functional compartmentation of ATP and creatine phosphate in heart muscle. J. Mol. Cell. Cardiol. 1:325–339.PubMedCrossRefGoogle Scholar
  11. 11.
    Hohorst, H.-J. 1970. L-(+)-Lactat. Bestimmung mit Lactat-Dehydrogenase und NAD. In: H. U. Bergmeyer (ed.), Methoden der Enzymatischen Analyse II, pp. 1425–1429. Verlag Chemie, Weinheim.Google Scholar
  12. 12.
    Katsuki, S., Arnold, W. P., and Murad, F. 1977. Effects of sodium nitroprusside, nitroglycerin and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. J. Cyclic Nucleotide Res. 3:239–247.PubMedGoogle Scholar
  13. 13.
    Katz, A. M. 1977. Physiology of the Heart, pp. 420–428. Raven Press, New York.Google Scholar
  14. 14.
    Katz, A. M., and Hecht, H. H. 1969. The early “pump” failure of the ischemic heart. Am. J.Med. 47:497–501.PubMedCrossRefGoogle Scholar
  15. 15.
    Krause, E. G., and Wollenberger, A. 1980. Cyclic nucleotides in acute myocardial ischemia and hypoxia. Adv. Cyclic Nucleotide Res. 12:49–61.PubMedGoogle Scholar
  16. 16.
    Lambrecht, W., Stein, P., Heinz, F., and Weisser, H. 1970. Creatinphosphat. In: H. U. Bergmeyer (ed.), Methoden der Enzymatischen Analyse II, pp. 1729–1733. Verlag Chemie, Weinheim.Google Scholar
  17. 17.
    Lebedev, A. V., Levitsky, D. O., and Loginov, V. A. 1980. Lipid hydroperoxides as indicators of cation permeability through biological membranes (simplest calcium channel). J. Mol. Cell. Cardiol. 12(Suppl. 1):92.Google Scholar
  18. 18.
    Meinertz, T., Nawrath, H., and Scholz, H. 1973. Dibutyryl cyclic AMP and adrenaline increase contractile force and 45Ca uptake in mammalian cardiac muscle. Naunyn Schmiedebergs Arch. Pharmacol. 277:107–112.PubMedCrossRefGoogle Scholar
  19. 19.
    Metsä-Ketelä, T., Laustiola, K., Lilius, E.-M., and Vapaatalo, H. 1980. On the role of cyclic nucleotides in the regulation of cardiac contractility and glycolysis during hypoxia. Acta Pharmacol. Toxicol. (Kbh.) 48:311–319.CrossRefGoogle Scholar
  20. 20.
    Neely, J. R., Whitmer, K. M., and Mochizuki, S. 1976. Effects of mechanical activity and hormones on myocardial glucose and fatty acid utilization. Circ. Res. 38(Suppl. I):22–29.Google Scholar
  21. 21.
    Rau, E. E., and Langer, G. A. 1978. Dissociation of energetic state and potassium loss from anoxic myocardium. Am. J. Physiol. 235:H537-H543.PubMedGoogle Scholar
  22. 22.
    Robison, G. A., Butcher, R. W., and Sutherland, E. W. 1971. Cyclic AMP. Academic Press, New York.Google Scholar
  23. 23.
    Steenbergen, C., Geleew, G., Rich, T., and Williamson, J. R. 1977. Effects of acidosis and ischemia on contractility and intracellular pH of rat heart. Circ. Res. 41:849–858.PubMedCrossRefGoogle Scholar
  24. 24.
    Tsien, R. W. 1977. Cyclic AMP and contractile activity in heart. Adv. Cycl. Nucl. Res. 9:363–420.Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • T. Metsä-Ketelä
    • 1
  • K. Laustiola
    • 1
  • H. Vapaatalo
    • 1
  1. 1.Department of Biomedical SciencesUniversity of TampereTampere 10Finland

Personalised recommendations